2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]
RxNorm concept 2055650, branded drug (sbd). Prescribable name: TAKHZYRO 300 MG in 2 ML Injection.
- RxCUI
- 2055650
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2055650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
2 ML Takhzyro 150 MG/ML Injection; Takhzyro 300 MG per 2 ML Injection
Related concepts
- lanadelumab-flyo 150 MG/ML (SCDC, consists of)
- lanadelumab-flyo 150 MG/ML [Takhzyro] (SBDC, consists of)
- Injection (DF, has dose form)
- Takhzyro (BN, has ingredient)
- 2 ML lanadelumab-flyo 150 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
- 47783064401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2055650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2055650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2055650. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.